Method for preparing dabigatran etexilate intermediate, and intermediate compound

US10112901B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10112901-B2
Application numberUS-201415323709-A
CountryUS
Kind codeB2
Filing dateJul 3, 2014
Priority dateJul 3, 2014
Publication dateOct 30, 2018
Grant dateOct 30, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are a method for preparing a dabigatran etexilate intermediate, and an intermediate compound. The method for preparing a dabigatran etexilate intermediate 4 comprises: reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent, wherein, X=chlorine, bromine, or iodine. Also disclosed are an intermediate compound 3 and a preparation method thereof. The method for preparing a dabigatran etexilate intermediate of the present invention has the advantages of simple process, easy operation, high yield, and easy purification, thus being suitable for industrial production.

First claim

Opening claim text (preview).

What is claimed is: 1. A preparation method of a dabigatran etexilate intermediate 4, comprising: reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent, wherein the organic solvent is a erotic organic solvent or an aprotic organic solvent; and wherein, X=chlorine, bromine, or iodine. 2. The preparation method according to claim 1 , wherein the protic organic solvent is methanol and/or ethanol, and the aprotic organic solvent is an aprotic polar organic solvent. 3. The preparation method according to claim 2 , wherein the aprotic organic solvent is one or more of dimethyl sulfoxide, N,N-dimethyl formamide, N,N-dimethyl acetamide, and N-methyl pyrrolidone. 4. The preparation method according to claim 1 , wherein the C 1 -C 3 alkyl alcohol solution of methylamine is one or more of a methanol solution of methylamine, an ethanol solution of methylamine, and a propanol solution of methylamine; and the concentration of the C 1 -C 3 alkyl alcohol solution of methylamine is 27-32% by weight. 5. The preparation method according to claim 1 , wherein the molar ratio of the compound 3 to methylamine is 1:1.98-1:2.35. 6. The preparation method according to claim 1 , wherein the C 1 -C 3 alkyl alcohol solution of methylamine is added by dripping the C alkyl alcohol solution of methylamine into a mixture of the compound 3 and the organic solvent. 7. The preparation method according to claim 1 , wherein when the organic solvent is a prone organic solvent, the reaction temperature is 30-40° C.; and when the organic solvent is an aprotic organic solvent, the reaction temperature is 60-90° C. 8. The preparation method according to claim 7 , wherein when the organic solvent is an aprotic organic solvent, the reaction temperature is 70° C. 9. The preparation method according to claim 1 , wherein the compound 3 is prepared through a method comprising: acylating a compound 2 with ethyl 3-(pyridin-2-yl-amino)propionate in dichloromethane and/or tetrahydrofuran in the presence of an organic base; and then the dabigatran etexilate intermediate 4 is prepared following the preparation method according to claim 1 , wherein, X=chlorine, bromine, or iodine. 10. The preparation method according to claim 9 , wherein the organic base is triethylamine and/or N,N-diisopropylethylamine. 11. The preparation method according to claim 9 , wherein the molar ratio of the compound 2 to ethyl 3-(pyridin-2-yl-amino)propionate is 1:1; the molar ratio of the organic base to the compound 2 is 1:1-2:1; and the acylation temperature is 0-30° C. 12. The preparation method according to claim 9 , wherein the volume/weight ratio of dichloromethane and/or tetrahydrofuran to the compound 2 is 4-7 ml/g. 13. The preparation method according to claim 9 , wherein the compound 2 is added by dripping a mixture of the compound 2 and dichloromethane and/or tetrahydrofuran into a mixture of ethyl 3-(pyridin-2-yl-amino)propionate and the organic base. 14. A compound having a structure represented by wherein, X=chlorine, bromine, or iodine. 15. A preparation method of the compound 3, represented by: the preparation method comprising: acylating a compound 2 with ethyl 3-(pyridin-2-yl-amino)propionate in dichloromethane and/or tetrahydrofuran in the presence of an organic base, wherein, X=chlorine, bromine, or iodine; and the reaction conditions in the preparation method are as defined in claim 9 .

Assignees

Inventors

Classifications

  • C07D213/75Primary

    Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10112901B2 cover?
Disclosed are a method for preparing a dabigatran etexilate intermediate, and an intermediate compound. The method for preparing a dabigatran etexilate intermediate 4 comprises: reacting a compound 3 with a C 1 -C 3 alkyl alcohol solution of methylamine in an organic solvent, wherein, X=chlorine, bromine, or iodine. Also disclosed are an intermediate compound 3 and a preparation method thereof…
Who is the assignee on this patent?
Shanghai Inst Pharmaceutical Ind, China State Inst Pharm Ind, Chia Tai Tianqing Pharmaceutical Group Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D213/75. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).